Drug class in one race
IL-17A/F drugs for Psoriasis
3 tracked IL-17A/F drugs in the Psoriasis race. The class explanation lives on the IL-17A/F page; the full indication pipeline across every mechanism is on the Psoriasis page.
1 approved / phase 42 Phase 2
Head-to-head evidence: bimekizumab vs ORKA-002 · ORKA-002 vs sonelokimab · bimekizumab vs sonelokimab